Tito Fojo
Drug Transport and Resistance Mechanisms · Oncology
Grants
No NSF/NIH grants on record.
Career Trajectory
Research Cluster Map
Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.
Potential Collaborators
Recent Publications
Last 2 years · showing 13 of 13Conflicts of interest and interpretive authority in oncology
European Journal of Cancer · 2026-05-29
Advances in Therapy · 2025-11-28
Abiraterone vs Enzalutamide Among US Veterans With Metastatic Hormone-Sensitive Prostate Cancer
JAMA Network Open · 2025-11-04 · 1 citations
Combined HDAC and eIF4A inhibition: A novel epigenetic therapy for pancreatic ductal adenocarcinoma
Drug Resistance Updates · 2025-10-05
The Oncologist · 2025-10-03
Leukemia & lymphoma/Leukemia and lymphoma · 2025-09-21
PubMed · 2025-08-04
Skimming the Median and the Problem of Exaggerated Survival Gains
JAMA Oncology · 2025-05-22 · 8 citations
Journal of Clinical Oncology · 2025-04-14 · 13 citations
Evidence for a reduction in number of cycles of immune checkpoint inhibitors
The Lancet Oncology · 2025-01-01 · 3 citations
bioRxiv (Cold Spring Harbor Laboratory) · 2024-09-11 · 1 citations
EBioMedicine · 2024-08-24 · 4 citations
A review of mitotane in the management of adrenocortical cancer
The Oncologist · 2024-07-22 · 21 citations